I'm almost as excited to see Brilacidin's effect on secondary infections (pneumonia) as I am it's virus-killing action. Though I suppose it might be hard to verify that if patients improve before they get to that point.
Wish I had more shares. I might have to scoop up just a bit more.
(7)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links